Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aldeyra Therapeu (NQ: ALDX ) 5.070 -0.180 (-3.43%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Aldeyra Therapeu < Previous 1 2 3 4 5 Next > 70 Biggest Movers From Friday May 02, 2022 Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners. Vaxxinity, Inc. (NASDAQ: VAXX)... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session April 29, 2022 Via Benzinga 48 Stocks Moving In Friday's Mid-Day Session April 29, 2022 Gainers Belite Bio Inc. ADR (NASDAQ: BLTE) shares surged 144.8% to $14.69. Belite Bio priced its 6 million ADS IPO at $6 per ADS. GTY Technology Holdings Inc. (NASDAQ:... Via Benzinga Mid-Morning Market Update: Markets Down; Nasdaq Falls 100 Points April 29, 2022 U.S. stocks traded lower this morning, with the Nasdaq Composite dropping around 100 points on Friday. Via Benzinga The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid April 29, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session April 29, 2022 Via Benzinga How To Attend Aldeyra Therapeutics Q1 2022 Earnings Conference Call April 29, 2022 Aldeyra Therapeutics (NASDAQ:ALDX) will host a conference call at 08:00 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. Via Benzinga The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia March 29, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Aldeyra Therapeutics: Q4 Earnings Insights March 17, 2022 Aldeyra Therapeutics (NASDAQ:ALDX) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... Via Benzinga The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More March 27, 2022 Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets. Via Benzinga The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data March 17, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Recap: Aldeyra Therapeutics Q4 Earnings March 17, 2022 Aldeyra Therapeutics (NASDAQ:ALDX) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... Via Benzinga Earnings Scheduled For March 17, 2022 March 17, 2022 Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is... Via Benzinga Aldeyra Therapeutics Earnings Preview March 16, 2022 Aldeyra Therapeutics (NASDAQ:ALDX) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement.... Via Benzinga The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings March 13, 2022 Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments... Via Benzinga Aldeyra Therapeutics Announces Publication Of Phase 2 Clinical Trial Of Reproxalap In Allergen Chamber Model February 01, 2022 Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today... Via Benzinga 55 Biggest Movers From Yesterday December 22, 2021 Gainers Reliance Global Group, Inc. (NASDAQ: RELI) shares jumped 78.7% to close at $5.45 on Tuesday after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) gained 44.8... Via Benzinga Mid-Afternoon Market Update: Dow Jumps Over 500 Points; Rite Aid Shares Spike Higher December 21, 2021 Toward the end of trading Tuesday, the Dow traded up 1.52% to 35,463.11 while the NASDAQ rose 2.10% to 15,295.45. The S&P also rose, gaining 1.55% to 4,638.74. The U.S. has... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session December 21, 2021 Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 58.26% to $1.82 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 28.4... Via Benzinga Mid-Day Market Update: Crude Oil Rises 3%; Aldeyra Therapeutics Shares Slide December 21, 2021 Midway through trading Tuesday, the Dow traded up 1.15% to 35,332.22 while the NASDAQ rose 0.94% to 15,122.12. The S&P also rose, gaining 0.80% to 4,605.08. The U.S. has the... Via Benzinga 38 Stocks Moving In Tuesday's Mid-Day Session December 21, 2021 Gainers Reliance Global Group, Inc. (NASDAQ: RELI) surged 126% to $6.91 after gaining around 6% on Monday. Biofrontera Inc. (NASDAQ: BFRI) climbed 71.4% to $13.06 after gaining... Via Benzinga Stocks Set to Snap Selloff, Dow Eyes Triple-Digit Pop December 21, 2021 The major benchmarks look set to snap their three-day losing streak today, as investors reassess their anxieties over the fast-spreading omicron variant. Via Talk Markets The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail December 21, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CytomX Mid-Phase Study Of ADC In Lung And Head & Neck Cancer Patients... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session December 21, 2021 Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock moved upwards by 75.98% to $4.47 during Tuesday's pre-market session. The company's market cap stands at $62.8... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday December 21, 2021 Good morning, trader! We're kicking off the day with a dive into some of the biggest pre-market stock movers for Tuesday! Via InvestorPlace 10 Biggest Price Target Changes For Tuesday December 21, 2021 B of A Securities lifted the price target on Micron Technology, Inc. (NASDAQ: Via Benzinga 26 Stocks Moving in Tuesday's Pre-Market Session December 21, 2021 Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) rose 102% to $5.13 in pre-market trading after the company reported pan-coronavirus monoclonal antibody cocktail that retains... Via Benzinga Aldeyra's Dry Eye Disease Candidate Disappoints In Late-Stage Study December 21, 2021 Aldeyra Therapeutics Inc (NASDAQ: ALDX) reported topline data from Phase 3 TRANQUILITY Trial of reproxalap ophthalmic solution for dry eye disease. The trial... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session November 02, 2021 Gainers Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock increased by 16.73% to $14.86 during Tuesday's regular session. The current volume of 1.0 million shares is 269.7%... Via Benzinga Aldeyra's Dry Eye Disease Trial Meets Primary Endpoint, But Did Not Reach Statistical Significance November 02, 2021 Aldeyra Therapeutics Inc's (NASDAQ: ALDX) reproxalap achieved the primary endpoint of ocular redness in the Phase 2 trial in patients with dry eye disease. But the ... Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.